Evidence map›Paper›PMID 36537208›Full record

ArticleCardiovascular research2023

Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1β secretion.

Mustafa Yalcinkaya, Panagiotis Fotakis, Wenli Liu, Kaori Endo-Umeda, Huijuan Dou, Sandra Abramowicz, Tong Xiao, Peter Libby, Nan Wang, Alan R Tall and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Immune dysfunction in Alzheimer disease.Nature reviews. Neuroscience · 2026
    Review
  16. A pathology-to-single-cell framework links SPP1Journal of translational medicine · 2026
    Article
  17. Review
  18. Review
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Mustafa YalcinkayaDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, 630 West 168 Street P&S 8-401, New York, NY 10032, USA.
Panagiotis FotakisDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, 630 West 168 Street P&S 8-401, New York, NY 10032, USA.
Wenli LiuDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, 630 West 168 Street P&S 8-401, New York, NY 10032, USA.
Kaori Endo-UmedaDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, 630 West 168 Street P&S 8-401, New York, NY 10032, USA.
Huijuan DouDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, 630 West 168 Street P&S 8-401, New York, NY 10032, USA.
Sandra AbramowiczDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, 630 West 168 Street P&S 8-401, New York, NY 10032, USA.
Tong XiaoDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, 630 West 168 Street P&S 8-401, New York, NY 10032, USA.
Peter LibbyDepartment of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.ORCID 0000-0002-1502-502X
Nan WangDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, 630 West 168 Street P&S 8-401, New York, NY 10032, USA.
Alan R TallDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, 630 West 168 Street P&S 8-401, New York, NY 10032, USA.
Marit WesterterpDivision of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, 630 West 168 Street P&S 8-401, New York, NY 10032, USA.ORCID 0000-0003-2230-1659
Columbia University Irving Medical Center · USBrigham and Women's Hospital · USNihon University · JPUniversity Medical Center Groningen · NL

Funding

Cholesterol efflux, CHIP and inflammasome activationR01HL107653 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ALAN richard TALL · 2011 to 2026
$7.7M
Clonal hematopoiesis, inflammasomes and atherosclerosisR01HL155431 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ALAN richard TALL · 2021 to 2026
$3.7M
Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal HematopoiesisR01HL163099 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LIBBY, PETER · 2022 to 2025
$2.6M
Novel mechanisms of the thrombotic complications of atherosclerosisR01HL134892 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LIBBY, PETER · 2019 to 2022
$1.7M
NHLBI NIH HHS R01 HL107653NHLBI NIH HHS R01 HL134892NHLBI NIH HHS R01 HL155431NHLBI NIH HHS R01 HL163099
6 · The paper itself

Abstract

aimsNeutrophil extracellular trap formation (NETosis) increases atherosclerotic plaque vulnerability and athero-thrombosis. However, mechanisms promoting NETosis during atherogenesis are poorly understood. We have shown that cholesterol accumulation due to myeloid cell deficiency of the cholesterol transporters ATP Binding Cassette A1 and G1 (ABCA1/G1) promotes NLRP3 inflammasome activation in macrophages and neutrophils and induces prominent NETosis in atherosclerotic plaques. We investigated whether NETosis is a cell-intrinsic effect in neutrophils or is mediated indirectly by cellular crosstalk from macrophages to neutrophils involving IL-1β. METHODS AND

resultsWe generated mice with neutrophil or macrophage-specific Abca1/g1 deficiency (S100A8CreAbca1fl/flAbcg1fl/fl or CX3CR1CreAbca1fl/flAbcg1fl/fl mice, respectively), and transplanted their bone marrow into low-density lipoprotein receptor knockout mice. We then fed the mice a cholesterol-rich diet. Macrophage, but not neutrophil Abca1/g1 deficiency activated inflammasomes in macrophages and neutrophils, reflected by caspase-1 cleavage, and induced NETosis in plaques. NETosis was suppressed by administering an interleukin (IL)-1β neutralizing antibody. The extent of NETosis in plaques correlated strongly with the degree of neutrophil accumulation, irrespective of blood neutrophil counts, and neutrophil accumulation was decreased by IL-1β antagonism. In vitro, IL-1β or media transferred from Abca1/g1-deficient macrophages increased NETosis in both control and Abca1/Abcg1 deficient neutrophils. This cell-extrinsic effect of IL-1β on NETosis was blocked by an NLRP3 inhibitor.

conclusionThese studies establish a new link between inflammasome-mediated IL-1β production in macrophages and NETosis in atherosclerotic plaques. Macrophage-derived IL-1β appears to increase NETosis both by increasing neutrophil recruitment to plaques and by promoting neutrophil NLRP3 inflammasome activation.

Indexed as

Plaque, AtheroscleroticAnimalsCholesterolInflammasomesMacrophagesMiceMice, KnockoutNLR Family, Pyrin Domain-Containing 3 ProteinCholesterolInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinAtherosclerosisInflammationLeukocyte

Identifiers

PMID36537208
PMCPMC10153645
OpenAlexW4312019790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.